3Buster EH,Flink HJ,Simsek H. Early HBeAg loss during peginterferonα-2b therapy predicts HBsAg loss:Results of a long-term fol ow-up study in chronic hepatitis B patients[J].American Journal of Gastroenterology,2009,(10):2449-2457.
8Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
1Mele L, Muratori P, Cassani F, et al. Circulating non-organ specific autoantibodies (NOSA) and cryoglobulins(CG) in HCV-related chronic liver disease (CLD)[J]. Journal of Hepatotogv, 2003:38(2): 157-159.
2Kamme AR,Van SH,Grabsoheid B,et al.Molecular mimiery of human CylochromP450 by hepalitia C virus at the level of cylotoxie T eell recognition[J].J Exp Med,1999,190(2):169-170.
3SuttiS,Vidali M,Mombelloc,et al.Breaking self-tolerance toward cytoehrome P4502E1(cyP2E1)in chronic hepatitisC;Possible role for molecular mimicry[J].J Hepatol,2010,53:434-438.
4Kerkar N,Choudhuri K,Mahoud A,et al.Cytochrome P4502D6(193-212):a new immumodomin ant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type positive liver disease[J].J Immunol,2003,170:1481-1489.
5Kamme AR, Van der Burg SH , Grabsoheid B, et al. Molecular mimiery of human Cylochrom P450 by hepalitia C virus at the level ofcylotoxie T cell recognition [J ] . J Exp Med, 1999, 190 ( 2 ) : 169.
6SuttiS, Vidali M, Mombello C, et al. Breaking self-tolerance toward cytoehrome P4502E1 (cyP2E1) in chronic hepatitis C." Possible role for molecular mimicry [J ] . J Hepatol, 2010, 53 ( 3 ) : 434-438.
7Kerkar N, Choudhuri K, Mahoud A, et al. Cytochrome P4502D6 (193-212) : anew epitope and target of virus/ self cross-reactivity in liver kidney microsomal autoantibody type positive liver disease [J ] . J Immunol, 2003, 170 (3) : 1481- 1489.
